BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
T cell receptor signaling pathway
,
Influenza
,
Endothelial cell
,
Alcohol
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IGHV4-34
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
B lymphocyte (naive) of spleen
B lymphocyte (IgM memory) of spleen
Tonsil
Stomach pyloric
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphoc…
Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasak…
A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas ex…
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Feat…
Lymphoplasmacytic lymphoma presenting cold agglutinin syndrome: Clonal expansion of KMT2D and IGHV4-…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed…
Binimetinib for People With Relapsed/Refractory BRAF Wild Type Hairy Cell Leukemia and Variant
Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed…
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ